17452-14-1Relevant articles and documents
Method for preparing cyclic thiourea compound
-
Paragraph 0017-0018, (2021/12/07)
The method comprises the following steps: suspending metal hydride in anhydrous THF, dropwise adding ring thiourea in the stirring process, stirring at room temperature after completion of stirring, stirring at room temperature, TLC monitoring reaction co
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
Zhan, Peng,Liu, Xinyong,Zhu, Junjie,Fang, Zengjun,Li, Zhenyu,Pannecouque, Christophe,Clercq, Erik De
experimental part, p. 5775 - 5781 (2009/12/28)
A series of 2-(1-aryl-1H-imidazol-2-ylthio)acetamide [imidazole thioacetanilide (ITA)] derivatives were synthesized and evaluated as potent inhibitors of human immunodeficiency virus type-1 (HIV-1). Among them, the most potent HIV-1 inhibitors were 4a5 (E
New bis(mercaptoimidazolyl)(pyrazolyl)borate ligands and their zinc complex chemistry
Shu, Mouhai,Walz, Rainer,Wu, Biao,Seebacher, Jan,Vahrenkamp, Heinrich
, p. 2502 - 2511 (2007/10/03)
Nine new tripodal NS2 ligands of the bis(mercaptoimidazolyl)(pyrazolyl)borate type with varying 3-R-mercaptoimidazolyl moieties were prepared as their potassium salts. Treatment with zinc salts yielded the complex types L·Zn-Cl, L·Zn-I, L·Zn-ONO2, L·Zn-OClO3 and [L·Zn(imidazole)]ClO4. Attempts at the formation of L·Zn-OH or cationic L·Zn complexes resulted in dismutation and formation of ZnL2 complexes. Hydrolytic destruction yielded one [OZn4(thiooimidazolate)6] complex. The ZnS2NO coordination which is present in the enzyme-substrate complex of alcohol dehydrogenase could be successfully modelled by an [L·Zn(C2H5OH)]+ complex. The L·Zn-X complexes showed very low catalytic activity in the dehydrogenation of 2-propanol or the hydrogenation of p-nitrobenzaldehyde. The new compounds were identified by a total of 12 structure determinations. Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003.
DOPAMINE-BETA-HYDROXYLASE INHIBITORS
-
, (2008/06/13)
Potent dopamine-beta-hydroxylase inhibitors having the Formula that are useful to inhibit dopamine-beta-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine-beta-hydroxylas
2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors
-
, (2008/06/13)
Potent dopamine-β-hydroxylase inhibitors having the Formula STR1 that are useful to inhibit dopamine-β-hydroxylase activity, pharmaceutical compositions including these inhibitors, and methods of using these inhibitors to inhibit dopamine-β-hydroxylase ac